Pediatric Diabetes

 Oral contraception in adolescents with type 1 diabetes and its association with cardiovascular risk factors. A multicentre DPV study on 24,011 patients from Germany, Austria, or Luxembourg
 
Objective To investigate differences in cardiovascular risk factors and metabolic control in girls with type 1 diabetes with or without use of oral contraceptives (OC) from the multicentre ?diabetes prospective follow-up? registry (DPV). Methods 24,011 adolescent girls (13-<18 years of age) from Germany, Austria or Luxembourg with type 1 diabetes from the DPV registry were included in this cross-sectional study. Multivariable regression models were applied to compare clinical characteristics (HbA1C, blood pressure, serum lipids, BMI) and lifestyle factors (smoking, physical inactivity, alcohol consumption) between girls with or without OC use. Confounders: Age, diabetes duration, and migration background. Statistical analysis: SAS 9.4. Results In girls with type 1 diabetes and OC use, clinical characteristics and lifestyle factors were less favorable compared to non-users. Differences were most pronounced for the prevalence of dyslipidemia (OC-users: 40.0% vs. non-users: 29.4; p<0.0001) and the number of smokers (OC-users: 25.9% vs. non-users: 12.5%; p<0.0001). OC use, sociodemographic characteristics and lifestyle factors explained between 1%-7% of the population variance in serum lipids and blood pressure. The use of OC explained a small additional proportion in all variables considered (<1%). Conclusions OC use in adolescent girls with type 1 diabetes was associated with a poorer cardiovascular risk profile. Biological risk factors were partly explained by a clustering of sociodemographic and lifestyle factors with a small additional contribution of OC use. Prescription of OC should therefore be combined with a screening for cardiovascular risk factors and targeted education.